4.7 Review

Key Role of Mesenchymal Stromal Cell Interaction with Macrophages in Promoting Repair of Lung Injury

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19

Dhanashree Murugan et al.

Summary: This article discusses the advantages of stem cell therapy for COVID-19 and the immunomodulatory effects of stem cells from different sources. Clinical trials have demonstrated promising results for exosome-based and MSC-based therapies in treating COVID-19.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2023)

Article Respiratory System

Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis

Yue Su et al.

Summary: This study found that MSC EVs have immunomodulatory effects in ARDS through the miR-181a-PTEN-pSTAT5-SOCS1 pathway.

THORAX (2023)

Review Biochemistry & Molecular Biology

Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications

Lijun Chen et al.

Summary: This review discusses the origins, pathogenesis, and clinical features of COVID-19, as well as the potential uses of mesenchymal stem cells (MSCs) in treating patients infected with SARS-CoV-2. Preliminary data from ongoing clinical trials are promising, but long-term safety evaluations and larger trials are needed for more conclusive judgments regarding MSC-based therapies.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Review Immunology

The impact of the lung environment on macrophage development, activation and function: diversity in the face of adversity

Calum C. Bain et al.

Summary: The last decade has seen significant advances in the field of macrophage biology, particularly in our understanding of their heterogeneity, ontogeny, metabolism, and function in both health and disease. Future research should focus on further advancing core concepts and addressing key unanswered questions.

MUCOSAL IMMUNOLOGY (2022)

Article Nutrition & Dietetics

Regulatory Effects of Quercetin on M1/M2 Macrophage Polarization and Oxidative/Antioxidative Balance

Cheng-Fang Tsai et al.

Summary: Macrophage polarization plays essential roles in various diseases, and the natural compound quercetin has been found to inhibit inflammation and enhance M2 macrophage polarization and antioxidant expression. These findings are important for the potential use of quercetin as a drug for the treatment of inflammatory disorders in the central nervous system.

NUTRIENTS (2022)

Article Biochemistry & Molecular Biology

IL-33 regulates M1/M2 chemokine expression via mitochondrial redox-related mitophagy in human monocytes

Yi-Ching Lin et al.

Summary: IL-33 induces ROS production in monocytes and regulates mitophagy through the AMPK pathway. IL-33 also alters the polarization phenotype of monocytes.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Article Cell & Tissue Engineering

Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow Niche

Inci Cevher Zeytin et al.

Summary: This study investigates the alterations in the HSC and MSC components of the osteopetrotic niche, as well as their interactions, to mimic stem cell dynamics/trafficking in the bone marrow niche after HSC transplantation. The findings suggest significant changes in both the MSC and HPC compartments of the osteopetrotic niche and highlight the impact of functionally impaired osteoclasts on defective niche formation.

STEM CELLS TRANSLATIONAL MEDICINE (2022)

Review Biochemistry & Molecular Biology

Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19

Ju-Pi Li et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has posed a significant global public health challenge. Despite mass vaccination, the emergence of novel viral variants has increased the risks of reinfections and vaccine breakthrough infections. Cytokine storm leading to acute respiratory distress syndrome is the major cause of mortality in COVID-19 patients. Mesenchymal stem cells (MSCs) have immunomodulatory, tissue repair, and antiviral properties, making them a potential treatment for COVID-19.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

hLMSC Secretome Affects Macrophage Activity Differentially Depending on Lung-Mimetic Environments

Bryan Falcones et al.

Summary: MSC-based therapies for inflammatory diseases rely on their paracrine ability to modulate macrophage activity. This study found that physiomimetic cultures can alter the secretome of MSCs and influence macrophage activity. Lung-derived hydrogels showed different secretions compared to conventionally cultured samples, and secretome from lung-mimetic environments resulted in decreased phagocytic capacity and M1 subtype of macrophages.
Review Cell Biology

Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19

Jitendra Kumar Chaudhary et al.

Summary: SARS-CoV-2 is an enveloped positive sense single-stranded RNA virus that primarily spreads through respiratory droplets. It affects the lungs and can cause a range of symptoms, from asymptomatic to severe. The virus triggers an immune response that can lead to a cytokine storm and tissue damage. Mesenchymal stem cells (MSCs) may be a potential supportive therapy due to their immunomodulatory and regenerative properties, helping to reduce disease severity and promote recovery.
Article Cell & Tissue Engineering

Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK/STAT pathways

Na Dong et al.

Summary: The study showed that intratracheal administration of hUC-MSCs improved hyperoxia-induced lung, heart, and kidney injuries by reducing inflammation and oxidative damage, and activating HO-1 expression and JAK/STAT signaling. The therapeutic benefits of local intratracheal and intraperitoneal administration were found to be equivalent.

WORLD JOURNAL OF STEM CELLS (2022)

Review Cell Biology

Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome

Chang Liu et al.

Summary: This review discusses the pathogenesis of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and the biological characteristics and mechanisms of mesenchymal stromal cells (MSCs) in the treatment of ALI/ARDS.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Immunology

ACT001 suppressing M1 polarization against inflammation via NF-?B and STAT1 signaling pathways alleviates acute lung injury in mice

Hui Guo et al.

Summary: This study found that ACT001 significantly alleviates inflammation and limits the M1 phenotype of pulmonary macrophages by suppressing NF-Kappa B and STAT1 signaling pathways in acute lung injury (ALI).

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Critical Care Medicine

Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial

Antoine Monsel et al.

Summary: The efficacy of UC-MSCs in patients with SARS-CoV-2-induced ARDS was assessed in this study. The results showed no significant difference in respiratory indicators between the UC-MSCs and placebo groups. The repeated UC-MSCs infusions did not lead to any serious adverse events during treatment or thereafter.

CRITICAL CARE (2022)

Article Endocrinology & Metabolism

Mitochondrial transfer from mesenchymal stem cells improves neuronal metabolism after oxidant injury in vitro: The role of Miro1

Nancy Tseng et al.

Summary: This study examines the role of mitochondrial transfer from MSC to neurons in neuronal preservation after oxidant injury. The transfer of mitochondria led to increased neuronal survival and improved metabolism. Regulation of the Miro1 gene expression can affect the metabolic benefit of mitochondrial transfer.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)

Article Cell & Tissue Engineering

Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells

Richard Schaefer et al.

Summary: Studies have shown that MSCs carry receptors and are resistant to SARS-CoV-2 infection under steady-state and inflammatory conditions, with their immunomodulation potential remaining intact in the presence of the virus. This suggests the potential applicability of MSCs for COVID-19 treatment.

STEM CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises

Leila Rezakhani et al.

Summary: Currently, there is a lack of effective antiviral medications or vaccines available for COVID-19, highlighting the urgent need for new treatment options. Inflammation induced by the virus often leads to acute respiratory distress syndrome (ARDS), emphasizing the importance of controlling inflammation. Research suggests that using mesenchymal stem cells and exosomes could potentially help suppress inflammation.

CHEMISTRY AND PHYSICS OF LIPIDS (2021)

Article Oncology

M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT

Yingwei Xie et al.

Summary: This study found that M2 macrophages in clear cell renal cell carcinoma are associated with poor prognosis, potentially promoting tumor proliferation, migration, and invasion through the secretion of chemokine CXCL13.

CANCER CELL INTERNATIONAL (2021)

Review Cell & Tissue Engineering

Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy

Mauro Krampera et al.

Summary: MSCs have shown exceptional safety in clinical trials, but reliable potency assays to predict their immunosuppressive efficacy are still lacking. They are approved for certain diseases in Japan and Europe, but not in the United States. Researchers discuss potential mechanisms of action, experimental models, and approaches for identifying MSC effects in vivo.

CELL STEM CELL (2021)

Article Biochemistry & Molecular Biology

Exosomes from adipose-derived stem cells alleviate the inflammation and oxidative stress via regulating Nrf2/HO-1 axis in macrophages

Kuo Shen et al.

Summary: ADSCs exosomes can polarize macrophages to an anti-inflammatory phenotype by regulating the expression of Nrf2 and HO-1, improving inflammation and organ injury in sepsis models.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Biochemistry & Molecular Biology

Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine

Vitale Miceli et al.

Summary: MSCs are multipotent adult stem cells that support tissue regeneration, and their therapeutic effects are derived from the secretion of bioactive molecules. However, variables in clinical trials have led to inconsistent outcomes. Therefore, exploring the paracrine action of MSCs to enhance therapeutic benefits by modulating the composition of secretome is a promising approach for tissue regeneration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell & Tissue Engineering

Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice

Liyang Dong et al.

Summary: Hypoxic human umbilical cord MSC-derived EVs attenuated allergic airway inflammation and airway remodeling in chronic asthma mice, potentially offering new avenues for asthma treatment.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell & Tissue Engineering

Inflammatory cytokines-stimulated human muscle stem cells ameliorate ulcerative colitis via the IDO-TSG6 axis

Shengchao Zhang et al.

Summary: This study demonstrates that human muscle stem cells treated with inflammatory factors can alleviate symptoms of inflammatory bowel disease through IDO-mediated TSG-6 production. Mechanistically, tryptophan metabolites produced by IDO enhance TSG-6 expression via activation of the common receptor AHR.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell & Tissue Engineering

Human umbilical cord mesenchymal stem cell-derived extracellular vesicles ameliorate airway inflammation in a rat model of chronic obstructive pulmonary disease (COPD)

Noridzzaida Ridzuan et al.

Summary: This study demonstrated the potential anti-inflammatory effects of human umbilical cord mesenchymal stem cell (hUC-MSC)-derived extracellular vesicles (EVs) in a rat model of COPD. Both hUC-MSCs and EVs were found to effectively ameliorate COPD-induced inflammation, suggesting that EVs could serve as a new cell-free-based therapy for the treatment of COPD.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell & Tissue Engineering

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial

Giacomo Lanzoni et al.

Summary: The study confirmed safety of UC-MSC infusions in patients with COVID-19 ARDS. By reducing inflammatory cytokines, significant improvement was observed in UC-MSC-treated patients on day 6. The treatment markedly increased patient survival rate, SAE-free survival, and time to recovery.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Cell & Tissue Engineering

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection

Maria A. Avanzini et al.

Summary: Research has shown that human MSCs derived from different tissues are not susceptible to SARS-CoV-2 infection, indicating the safety of MSCs as a potential therapy for COVID-19.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Review Oncology

Mesenchymal stem/stromal cells in cancer therapy

Tianxia Lan et al.

Summary: Multipotent mesenchymal stem/stromal cells (MSCs) have been identified in almost all tissues of the human body, showing potential in cancer treatment due to their multipotency, immunomodulation capacity, and tumor-homing property. However, controversial roles of MSCs in crosstalk with tumors hinder translational medicine progress.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Cell Biology

Tissue-Resident Macrophage Development and Function

Yinyu Wu et al.

Summary: This review discusses the developmental origins of tissue-resident macrophages, which are produced during three waves of hematopoietic development and reside in different tissues with specific functions. These tissue-resident macrophages are derived from primitive hematopoiesis, yolk sac EMP, and HSC, and play critical roles in embryonic development and postnatal homeostasis.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Role of miR-466 in mesenchymal stromal cell derived extracellular vesicles treating inoculation pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

Meng-meng Shi et al.

Summary: MiR-466 is highly expressed in MSC EVs, MSCs and miR-466 promote macrophage polarization towards Type 2 phenotype through the TIRAP-MyD88-NF kappa B axis. MSC EVs significantly reduce mortality in murine MDR-PA pneumonia, and administration of miR-466 overexpressing MSC EVs further alleviates inflammation severity.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Physiology

Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia

Andrea Porzionato et al.

Summary: The study demonstrated the protective effects of intratracheally-administered extracellular vesicles secreted by mesenchymal stem cells in a rat model of bronchopulmonary dysplasia, with prevention of morphometric changes induced by hyperoxia exposure in the long term. The findings further support the potential of intratracheally-administered EVs as an effective approach to prevent/treat BPD, with a possible role of M2 macrophage polarization.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Review Immunology

Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study

Meruyert Dauletova et al.

Summary: COVID-19, caused by SARS-CoV-2, has become a global pandemic that challenges the world health system and economy. The virus triggers a cytokine storm by inducing cell apoptosis and production of pro-inflammatory cytokines, leading to extensive tissue damage. The novel MSC therapy and exosome therapy show promising outcomes in treating COVID-19 patients.

CLINICAL IMMUNOLOGY (2021)

Article Immunology

Intranasal delivery of MSC-derived exosomes attenuates allergic asthma via expanding IL-10 producing lung interstitial macrophages in mice

Jiling Ren et al.

Summary: Research has shown that MSC-Exo can significantly alleviate allergic airway inflammation in mice with asthma by expanding IL-10-producing lung interstitial macrophages and alveolar macrophages, acting as an immunomodulatory effect.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Cell Biology

Macrophages in Lung Injury, Repair, and Fibrosis

Peiyong Cheng et al.

Summary: Fibrosis progression in the lung can lead to impaired gas exchange, respiratory failure, or even death. Macrophages play a crucial role in response to lung injury, repair, and fibrosis, with their activation and polarization being key factors in the process. Targeting macrophages may offer potential benefits in alleviating pulmonary fibrosis.
Article Oncology

Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial

Xiaowei Xu et al.

Summary: A study showed that using menstrual blood-derived MSCs to treat severe COVID-19 patients can reduce mortality, improve dyspnea, and increase oxygen saturation levels. This MSC-based therapy may be a promising alternative for treating severe COVID-19.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Extracellular Vesicles from Thapsigargin-Treated Mesenchymal Stem Cells Ameliorated Experimental Colitis via Enhanced Immunomodulatory Properties

Hansol Joo et al.

Summary: This study demonstrates that EVs secreted from WJ-MSCs primed with ER stress inducer TSG have enhanced immunomodulatory properties, showing potential for treating immune-mediated inflammatory diseases.

BIOMEDICINES (2021)

Article Physiology

Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice

Emily R. Siegel et al.

Summary: This experimental study highlights the important role of endogenous specialized proresolving mediators (SPMs) such as LXA4 and RvD1 in resolving lung injury caused by pneumococcal pneumonia. The mechanism of their benefits includes enhancing bacterial clearance and reducing pulmonary edema by restoring lung alveolar-capillary barrier permeability.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Article Medicine, General & Internal

Bone marrow-derived mesenchymal stem cells modulate autophagy in RAW264.7 macrophages via the phosphoinositide 3-kinase/protein kinase B/heme oxygenase-1 signaling pathway under oxygen-glucose deprivation/restoration conditions

Ning-Fang Wang et al.

Summary: This study investigated the influence of bone marrow-derived mesenchymal stem cells (BM-MSCs) on the autophagy of macrophages in the oxygen-glucose deprivation/restoration (OGD/R) microenvironment, revealing a potential mechanism involving the PI3K/Akt/HO-1 signaling pathway. The results suggest that BM-MSCs can regulate autophagy in macrophages, providing insights into potential therapeutic targets for acute lung injury (ALI) treatment.

CHINESE MEDICAL JOURNAL (2021)

Article Cell & Tissue Engineering

Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles

Mario Gimona et al.

Summary: Mesenchymal stromal/stem cells (MSCs) have been approved for treating certain diseases through paracrine secretion of small extracellular vesicles (sEVs). Despite the potential advantages of sEV preparations over cellular MSC products, there are challenges in developing MSC-sEV drug products, including establishing quality control metrics and developing effective potency assays.

CYTOTHERAPY (2021)

Article Biotechnology & Applied Microbiology

p-Coumaric acid regulates macrophage polarization in myocardial ischemia/reperfusion by promoting the expression of indoleamine 2, 3-dioxygenase

Na Li et al.

Summary: p-Coumaric acid modulates macrophage polarization by promoting IDO expression and attenuates macrophage-mediated inflammation following MI/R by promoting M2 macrophage polarization through IDO.

BIOENGINEERED (2021)

Review Biochemistry & Molecular Biology

Extracellular Vesicles from Mesenchymal Stromal Cells for the Treatment of Inflammation-Related Conditions

Sean T. Ryan et al.

Summary: MSC-derived EVs have shown therapeutic potential for treating inflammation-related conditions and have demonstrated efficacy in studies. They can serve as anti-inflammatory and pro-regenerative agents for diseases like osteoarthritis, rheumatoid arthritis, and Alzheimer's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Embryonic-Derived Myb- Macrophages Enhance Bacterial Clearance and Improve Survival in Rat Sepsis

Mirjana Jerkic et al.

Summary: Transplantation of embryonic-derived large peritoneal-like macrophages (Ed-LPM) attenuates abdominal fecal sepsis by enhancing peritoneal macrophage phagocytosis and killing of bacteria, reducing systemic sepsis severity, improving survival, and decreasing bacterial load.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing

Hazel Dunbar et al.

Summary: Clinical trials have shown significant benefits of MSC therapy for inflammatory conditions, but individual responses vary. Understanding how disease microenvironment affects MSC activation and therapeutic efficacy, as well as implementing patient stratification, is crucial for improving outcomes.
Article Cell Biology

Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta-analysis

Alvin Tieu et al.

Summary: Preclinical studies show that MSC-EVs have the potential to reduce inflammation and improve organ function in lung diseases, but greater transparency and direct comparisons of different methods and EV subtypes are needed to generate robust evidence.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Cell & Tissue Engineering

Exosomes from human umbilical cord mesenchymal stem cells attenuate the inflammation of severe steroid-resistant asthma by reshaping macrophage polarization

Bing Dong et al.

Summary: In this study, it was found that exosomes derived from human umbilical cord mesenchymal stem cells can ameliorate severe, steroid-resistant asthma by modulating macrophage polarization through inhibition of TRAF1.

STEM CELL RESEARCH & THERAPY (2021)

Review Pharmacology & Pharmacy

Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases

Linda Elowsson Rendin et al.

Summary: Research shows that the microenvironment plays a crucial role in cell behavior and therapeutic outcomes, suggesting that modulating the environmental context for cell-based therapy may help improve treatment effectiveness.

FRONTIERS IN PHARMACOLOGY (2021)

Review Critical Care Medicine

Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges

C. H. Masterson et al.

Summary: Severe viral pneumonia causes significant morbidity and mortality globally, with limited direct therapies available, mesenchymal stromal/stem cell therapy is considered a promising approach. Clinical trials have demonstrated safety of these cells, and strategies are being explored to enhance their therapeutic potential.

INTENSIVE CARE MEDICINE EXPERIMENTAL (2021)

Article Medicine, Research & Experimental

Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS

Katherine D. Wick et al.

Summary: The study shows that treatment with mesenchymal stromal cells significantly reduced lung injury biomarkers in ARDS patients. Airspace biomarkers provide additional value for studying the pathogenesis, treatment effects, and outcomes of ARDS.

JCI INSIGHT (2021)

Review Immunology

Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes

Maedeh Arabpour et al.

Summary: MSC-derived exosomes have the potential to polarize M2 macrophages and modulate inflammation in various diseases and conditions like CNS diseases, autoimmune diseases, inflammatory bowel disease, and cardiomyopathy.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Cell & Tissue Engineering

Human umbilical cord mesenchymal stromal cells attenuate pulmonary fibrosis via regulatory T cell through interaction with macrophage

Zan Tang et al.

Summary: HucMSC transplantation alleviates lung collagen accumulation and mortality in bleomycin-induced PF mice, promotes AT2 cell proliferation, inhibits lung fibroblast proliferation, and induces interferon-sensitive macrophages (IFNSMs) to secrete CXCL9 and CXCL10, recruiting more Treg cells to the injured lung.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell & Tissue Engineering

Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial

Ismail Hadisoebroto Dilogo et al.

Summary: The use of umbilical cord mesenchymal stromal cells (UC-MSCs) as adjuvant treatment for critically ill patients with COVID-19 significantly increases the survival rate by modulating the immune system towards an anti-inflammatory state.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Review Pharmacology & Pharmacy

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19

Shengguang Wang et al.

Summary: Lung alveolar type-II cells produce pulmonary surfactant, consisting of proteins and lipids which play crucial roles in preventing atelectasis and respiratory function. The SARS-CoV-2 virus damages these cells, leading to decreased production of pulmonary surfactant and contributing to the development of COVID-19. Clinical trials are underway to evaluate the potential therapeutic benefits of pulmonary surfactant in COVID-19 patients.

FRONTIERS IN PHARMACOLOGY (2021)

Article Cell Biology

Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury

Masahito Nakazaki et al.

Summary: Intravenous infusion of bone marrow-derived mesenchymal stem/stromal cells (MSCs) leads to the release of small extracellular vesicles (sEVs) that can target the injury site in spinal cord injury (SCI) rats and interact with M2 macrophages. Fractionated dosing of MSC-sEVs over 3 days is required to achieve therapeutic effects, mimicking the results of single MSC infusion. These findings suggest that the release of sEVs by MSCs over time induces a cascade of cellular responses leading to improved functional recovery.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Medicine, General & Internal

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial

Ellen Gorman et al.

Summary: The study outcomes suggest that a single intravenous infusion of ORBCEL-C is well tolerated in patients with moderate to severe ARDS, with no dose limiting toxicity reported within the experimental dose range.

ECLINICALMEDICINE (2021)

Review Medicine, Research & Experimental

Role of prostaglandin E2 in tissue repair and regeneration

Hui Cheng et al.

Summary: PGE2 plays a crucial role in tissue regeneration by promoting the regeneration of various organ systems through activation of endogenous stem cells, immune regulation, and angiogenesis. Understanding the modulation of tissue regeneration by PGE2 and enhancing its regenerative efficiency are crucial for tissue repair and regeneration processes.

THERANOSTICS (2021)

Article Cell & Tissue Engineering

Mitochondrial transfer from MSCs to macrophages restricts inflammation and alleviates kidney injury in diabetic nephropathy mice via PGC-1α activation

Yujia Yuan et al.

Summary: The study demonstrated that mesenchymal stem cells (MSCs) improved kidney injury in diabetic nephropathy (DN) mice by transferring mitochondria to macrophages, resulting in anti-inflammatory macrophage polarization. This process was mediated by peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) and TFEB, enhancing mitochondrial biogenesis and lysosome-autophagy in macrophages.

STEM CELLS (2021)

Review Cell & Tissue Engineering

Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity

Jacques Galipeau

Summary: Experimental evidence shows that host macrophages play a crucial role in mediating the anti-inflammatory properties of MSCs, while non-phagocytosed MSCs induce tissue macrophages to express IL-10, shaping the immune environment. MSC-derived factors such as IL-6, IDO, and TSG-6 directly influence macrophage polarization, highlighting a necessary functional relationship between MSCs and host macrophages in modulating inflammatory response.

STEM CELLS (2021)

Article Biochemistry & Molecular Biology

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

Lei Shi et al.

Summary: This study demonstrates that treatment with human umbilical cord-mesenchymal stem cells (UC-MSCs) can significantly improve lung lesions in COVID-19 patients and potentially have therapeutic effects in the 6-minute walk test. The incidence of adverse events was similar in both groups, indicating the good safety profile of UC-MSCs treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Cell & Tissue Engineering

First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline

Alexander Averyanov et al.

STEM CELLS TRANSLATIONAL MEDICINE (2020)

Review Respiratory System

The potential of mesenchymal stem cell therapy for chronic lung disease

Fernanda Ferreira Cruz et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)

Article Immunology

Dynamics of human monocytes and airway macrophages during healthy aging and after transplant

Adam J. Byrneee et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Medicine, General & Internal

MSC Based Therapies-New Perspectives for the Injured Lung

Judith Behnke et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Biotechnology & Applied Microbiology

Manipulation of macrophage polarization by peptide-coated gold nanoparticles and its protective effects on acute lung injury

Lu Wang et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Review Biochemistry & Molecular Biology

Extracellular Vesicles as Innovative Tool for Diagnosis, Regeneration and Protection against Neurological Damage

Pavle Andjus et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor

Jinsung Yang et al.

NATURE COMMUNICATIONS (2020)

Article Cell & Tissue Engineering

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Lei Shu et al.

STEM CELL RESEARCH & THERAPY (2020)

Review Cell Biology

Molecular Crosstalk Between Macrophages and Mesenchymal Stromal Cells

Hazel Y. Stevens et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Cell & Tissue Engineering

Human adipose mesenchymal stem cells modulate myeloid cells toward an anti-inflammatory and reparative phenotype: role of IL-6 and PGE2

Maitane Ortiz-Virumbrales et al.

STEM CELL RESEARCH & THERAPY (2020)

Review Cell & Tissue Engineering

Genetically Modified Mesenchymal Stromal/Stem Cells: Application in Critical Illness

Amir K. Varkouhi et al.

STEM CELL REVIEWS AND REPORTS (2020)

Article Cell & Tissue Engineering

Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors

Laura Saldana et al.

STEM CELL RESEARCH & THERAPY (2019)

Review Critical Care Medicine

Pathogenesis of Acute Respiratory Distress Syndrome

Laura A. Huppert et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Review Immunology

The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy

Daniel J. Weiss et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Immunology

The Metabolic Signature of Macrophage Responses

Antonella Viola et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Cell Biology

Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications

Kenneth W. Witwer et al.

JOURNAL OF EXTRACELLULAR VESICLES (2019)

Article Pathology

Diversity, Mechanisms, and Significance of Macrophage Plasticity

Massimo Locati et al.

Annual Review of Pathology-Mechanisms of Disease (2019)

Article Biochemistry & Molecular Biology

Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells

Zhaoyuan Liu et al.

Article Cell & Tissue Engineering

MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing

Xiaoning He et al.

STEM CELLS INTERNATIONAL (2019)

Editorial Material Immunology

Editorial: Alveolar Macrophages in Lung Inflammation and Resolution

Guochang Hu et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Critical Care Medicine

Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury

Diana Islam et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Review Cell Biology

M2b macrophage polarization and its roles in diseases

Le-xun Wang et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2019)

Article Critical Care Medicine

Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation

Gareth R. Willis et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Immunology

Implications of macrophage polarization in autoimmunity

Samanta C. Funes et al.

IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

Role of Human Macrophage Polarization in Inflammation during Infectious Diseases

Chiraz Atri et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Cell Biology

Macrophage plasticity, polarization, and function in health and disease

Abbas Shapouri-Moghaddam et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Article Immunology

Mesenchymal Stem Cells Recruit CCR2+ Monocytes To Suppress Allergic Airway Inflammation

Katsuyuki Takeda et al.

JOURNAL OF IMMUNOLOGY (2018)

Review Immunology

Mesenchymal-myeloid interaction in the regulation of immunity

Tik Shing Cheung et al.

SEMINARS IN IMMUNOLOGY (2018)

Article Cell & Tissue Engineering

Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia

Ian Mcclain-Caldwell et al.

CYTOTHERAPY (2018)

Article Cell & Tissue Engineering

Connexin 43-Mediated Mitochondrial Transfer of iPSC-MSCs Alleviates Asthma Inflammation

Yin Yao et al.

STEM CELL REPORTS (2018)

Article Biochemistry & Molecular Biology

Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells

Guan Wang et al.

CELL DEATH AND DIFFERENTIATION (2018)

Review Cell & Tissue Engineering

Concise Review: MSC-Derived Exosomes for Cell-Free Therapy

Donald G. Phinney et al.

STEM CELLS (2017)

Review Respiratory System

Mesenchymal stromal cell therapy in COPD: from bench to bedside

Mariana A. Antunes et al.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)

Article Critical Care Medicine

Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer

Thomas J. Morrison et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Article Biochemistry & Molecular Biology

Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties

Meriem Mahrouf-Yorgov et al.

CELL DEATH AND DIFFERENTIATION (2017)

Article Biochemistry & Molecular Biology

Mesenchymal Stromal Cells Deficient in Autophagy Proteins Are Susceptible to Oxidative Injury and Mitochondrial Dysfunction

Sailaja Ghanta et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)

Article Critical Care Medicine

Alveolar-like Stem Cell-derived Myb- Macrophages Promote Recovery and Survival in Airway Disease

Michael L. Litvack et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Article Immunology

IL-10-producing lung interstitial macrophages prevent neutrophilic asthma

Hideo Kawano et al.

INTERNATIONAL IMMUNOLOGY (2016)

Article Medicine, General & Internal

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

Giacomo Bellani et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Multidisciplinary Sciences

Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs

Donald G. Phinney et al.

NATURE COMMUNICATIONS (2015)

Article Critical Care Medicine

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial

Jennifer G. Wilson et al.

LANCET RESPIRATORY MEDICINE (2015)

Article Pharmacology & Pharmacy

Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis

Hyuk Min Kwon et al.

VASCULAR PHARMACOLOGY (2014)

Review Immunology

Alveolar macrophages: plasticity in a tissue-specific context

Tracy Hussell et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Review Cell & Tissue Engineering

Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation

Maria Ester Bernardo et al.

CELL STEM CELL (2013)

Article Immunology

Phagocytic Dysfunction of Human Alveolar Macrophages and Severity of Chronic Obstructive Pulmonary Disease

Charles S. Berenson et al.

JOURNAL OF INFECTIOUS DISEASES (2013)

Article Physiology

Bone marrow-derived mononuclear cells vs. mesenchymal stromal cells in experimental allergic asthma

Soraia C. Abreu et al.

RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2013)

Article Critical Care Medicine

Prostaglandin E2 As an Inhibitory Modulator of Fibrogenesis in Human Lung Allografts

Natalie M. Walker et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Article Pharmacology & Pharmacy

Azithromycin distinctively modulates classical activation of human monocytes in vitro

M. Vrancic et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

Review Cell Biology

Are mesenchymal stem cells major sources of safe signals in immune system?

Hanyu Wang et al.

CELLULAR IMMUNOLOGY (2012)

Review Transplantation

Mesenchymal stem cell-educated macrophages

Elke Eggenhofer et al.

TRANSPLANTATION RESEARCH (2012)

Article Immunology

Regulatory macrophages: Setting the Threshold for Therapy

Bryan D. Fleming et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2011)

Article Immunology

Macrophage pro-inflammatory cytokine secretion is enhanced following interaction with autologous platelets

Christopher M. Scull et al.

JOURNAL OF INFLAMMATION-LONDON (2010)

Article Multidisciplinary Sciences

Bone marrow stromal cells use TGF-β to suppress allergic responses in a mouse model of ragweed-induced asthma

Krisztian Nemeth et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Biotechnology & Applied Microbiology

Potential application of mesenchymal stem cells in acute lung injury

Jae Woo Lee et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2009)

Article Medicine, Research & Experimental

Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice

Denis Bedoret et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Immunology

Revisiting Crohn's disease as a primary immunodeficiency of macrophages

Jean-Laurent Casanova et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Allergy

Surfactant protein D inhibits TNF-α production by macrophages and dendritic cells in mice

Laszlo Hortobagyi et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)

Review Immunology

Prostaglandin E-2 synthesis and secretion: The role of PGE(2) synthases

Jean Y. Park et al.

CLINICAL IMMUNOLOGY (2006)